Investing

RAD receives IND approval from US FDA for Betabart (RV-01)

by admin
RAD receives IND approval from US FDA for Betabart (RV-01)

Radiopharm Theranostics (RAD:AU) has announced RAD receives IND approval from US FDA for Betabart (RV-01)

Download the PDF here.

This post appeared first on investingnews.com

Related Posts

Allied Critical Metals Joins the Critical Minerals Forum...

September 3, 2025

Oversubscribed Share Purchase Plan Raises $1.5 Million

November 27, 2025

JZR Gold

October 22, 2025

South Harz Potash Limited

July 1, 2025

Battery Storage Market Surging as Electricity Demand Enters...

November 28, 2025

VVC – Purchase of Ithaca 1-17 Well and...

October 10, 2025

Rio Silver arranges $1.3M private placement

September 12, 2025

What is the Santa Claus Rally and Has...

December 25, 2025

Nickel Price Update: Q3 2025 in Review

October 30, 2025

Crypto Market Update: FalconX to Buy 21Shares, Senate...

October 23, 2025